+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiac Marker Testing Market - Global Forecast 2026-2032- Product Image
Cardiac Marker Testing Market - Global Forecast 2026-2032- Product Image
Sale

Cardiac Marker Testing Market - Global Forecast 2026-2032

  • Report

  • 185 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4995396
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cardiac Marker Testing Market is projected to reach USD 9.82 Billion in 2026. It is expected to continue growing at a CAGR of 13.67%, reaching USD 21.40 Billion by 2032.

Cardiac marker testing is central to the rapid diagnosis, risk stratification, and monitoring of acute coronary syndrome, heart failure, myocarditis, thromboembolism, and other cardiovascular conditions. High-sensitivity cardiac troponin I and T remain the benchmark biomarkers for myocardial injury, while BNP and NT-proBNP support heart failure evaluation, and markers such as CK-MB, myoglobin, D-dimer, hs-CRP, and emerging multimarker panels provide complementary clinical context.

Demand is supported by the persistent global burden of cardiovascular disease, which the World Health Organization identifies as the leading cause of death worldwide, causing an estimated 17.9 million deaths each year. As emergency departments, clinical laboratories, and point-of-care settings prioritize faster turnaround times and guideline-aligned testing, the cardiac marker testing market is shifting toward high-sensitivity assays, automated platforms, connected diagnostics, and evidence-based clinical decision pathways.

Transformative Shifts in the Cardiac Marker Testing Landscape

The cardiac marker testing landscape is being reshaped by the movement from conventional biomarkers to high-sensitivity and quantitative assays that detect myocardial injury earlier and with greater analytical precision. This transition supports accelerated rule-in and rule-out algorithms for suspected myocardial infarction, reducing unnecessary admissions while improving patient triage in emergency and urgent care environments.

Another transformative shift is the expansion of testing beyond centralized laboratories. Point-of-care cardiac marker analyzers, integrated laboratory information systems, and sample-to-result workflow automation are enabling faster clinical action. At the same time, stricter quality requirements under frameworks such as CLIA, FDA oversight, CE marking, and the EU In Vitro Diagnostic Regulation are pushing assay developers to demonstrate stronger analytical validity, clinical performance, traceability, and post-market surveillance.

Cumulative Impact of Artificial Intelligence on Cardiac Marker Testing

Artificial intelligence is increasingly influencing cardiac marker testing by improving clinical interpretation rather than replacing biomarker science. AI-enabled decision support can combine troponin kinetics, patient history, electrocardiogram findings, age, sex-specific thresholds, renal function, and comorbidities to support more accurate risk stratification for acute coronary syndrome and heart failure.

The cumulative impact is expected to be strongest in workflow optimization, predictive analytics, and quality control. Machine learning models can identify outlier assay performance, reduce diagnostic delays, support population-level surveillance, and enable personalized care pathways. However, adoption depends on transparent validation, bias monitoring, cybersecurity safeguards, clinical governance, and alignment with regulatory expectations for software as a medical device.

Key Regional Insights for Cardiac Marker Testing

North America remains a leading region for cardiac marker testing due to advanced hospital infrastructure, high emergency care utilization, broad access to high-sensitivity troponin assays, and established reimbursement pathways. The United States and Canada continue to support adoption through clinical guideline adherence, laboratory automation, emergency department chest-pain protocols, and active investment in connected diagnostics.

Europe shows strong uptake driven by established cardiology networks, the European Society of Cardiology’s support for accelerated high-sensitivity troponin algorithms, and harmonized regulatory scrutiny under the In Vitro Diagnostic Regulation. Asia-Pacific is expanding rapidly as China, India, Japan, South Korea, Australia, and ASEAN health systems invest in hospital capacity, emergency medicine, chronic cardiovascular disease management, and local diagnostic manufacturing capabilities.

Latin America, the Middle East, and Africa present uneven but important opportunities shaped by access, affordability, and infrastructure. Brazil and Mexico are strengthening cardiac diagnostic access in urban centers and private hospital networks, GCC countries are investing in advanced hospital systems and preventive cardiology programs, and African markets are prioritizing scalable, affordable testing solutions that can address delayed diagnosis, limited laboratory reach, and growing noncommunicable disease burdens.

Key Group Insights Across ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are seeing greater demand for affordable point-of-care and hospital-based cardiac marker testing as urbanization, diabetes, hypertension, and improved emergency care capacity increase diagnostic utilization. BRICS countries, led by China, India, Brazil, and supported by large public health systems, are important demand centers because of sizable patient populations, expanding healthcare infrastructure, and policy attention to domestic diagnostic manufacturing and supply resilience.

The European Union is characterized by high regulatory expectations, clinical standardization, and growing adoption of high-sensitivity assays under IVDR compliance. GCC countries are adopting premium diagnostics as part of broader health system modernization and cardiovascular prevention strategies, while G7 nations remain innovation hubs for advanced immunoassay platforms, automation, AI-enabled diagnostics, laboratory accreditation, and reimbursement-backed clinical adoption. NATO countries broadly benefit from mature hospital networks, coordinated procurement practices, and resilient diagnostic supply chains that support continuity of critical cardiac testing.

Key Country Insights for Major Cardiac Marker Testing Markets

The United States leads in advanced cardiac marker testing adoption due to high emergency department volumes, FDA-cleared assays, strong laboratory networks, and integration of high-sensitivity troponin into clinical pathways. Canada emphasizes standardized care and regional laboratory systems, while Mexico and Brazil are expanding access through public and private hospital investments, urban cardiology networks, and broader availability of automated immunoassay platforms.

In Europe, the United Kingdom, Germany, France, Italy, and Spain show mature adoption of high-sensitivity troponin and natriuretic peptide testing, supported by cardiology guidelines, emergency care protocols, and centralized laboratory quality systems. Russia continues to rely on hospital-based diagnostics with opportunity for modernization in assay platforms, emergency workflows, and wider adoption of standardized cardiac biomarker pathways.

Across Asia-Pacific, China and India represent high-volume growth markets supported by rising cardiovascular disease prevalence, expanding diagnostic infrastructure, and increased investment in tertiary hospitals. Japan and South Korea emphasize technology-driven, high-quality assays, laboratory automation, and quality assurance, while Australia benefits from advanced emergency care systems, strong laboratory accreditation practices, and guideline-based chest-pain assessment.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated high-sensitivity troponin, BNP, and NT-proBNP assays that integrate seamlessly with emergency department workflows and laboratory automation platforms. Competitive differentiation will depend on faster turnaround time, strong analytical sensitivity, lower sample volume, interoperability with electronic health records, clear quality-control processes, and evidence supporting improved patient outcomes.

Organizations should also build regional strategies that address affordability, regulatory compliance, and healthcare infrastructure maturity. Partnerships with hospitals, reference laboratories, AI developers, and public health agencies can accelerate adoption, while robust post-market performance monitoring, supply-chain resilience, and clinician education will be essential to sustain trust in cardiac marker testing technologies.

Research Methodology for Cardiac Marker Testing Analysis

This executive summary applies a secondary research-led methodology using verified public health, clinical, regulatory, and industry sources. Key inputs include cardiovascular disease burden data from global health authorities, guideline-based biomarker practices from cardiology organizations, regulatory expectations from major diagnostic markets, and observable adoption trends across hospital laboratories, emergency departments, and point-of-care environments.

Insights are synthesized through market segmentation by biomarker type, testing location, technology platform, end user, region, economic group, and country. The analysis emphasizes data-backed trends, clinical utility, regulatory readiness, workflow impact, and commercial feasibility while avoiding unsupported market-size claims, market share assumptions, or speculative forecasts.

Conclusion: Outlook for Cardiac Marker Testing

Cardiac marker testing is evolving from a laboratory-dependent diagnostic function into a connected, high-sensitivity, and workflow-driven component of cardiovascular care. As cardiovascular disease remains the world’s leading cause of mortality, reliable biomarker testing will continue to play a critical role in early diagnosis, risk stratification, treatment monitoring, and hospital resource optimization.

The strongest opportunities will emerge where analytical performance, AI-enabled interpretation, point-of-care access, and regulatory compliance align. Organizations that combine clinical evidence with scalable platforms, strong quality systems, and region-specific commercialization strategies will be best positioned to capture growth in the cardiac marker testing market.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cardiac Marker Testing Market, by Marker Type
7.1. Introduction
7.2. CK-MB
7.3. LDH
7.4. Myoglobin
7.5. Troponin I
7.5.1. Conventional Troponin I
7.5.2. High Sensitivity Troponin I
7.6. Troponin T
7.6.1. Conventional Troponin T
7.6.2. High Sensitivity Troponin T
8. Cardiac Marker Testing Market, by Product
8.1. Introduction
8.2. Assay Kits
8.2.1. Multiplex Kits
8.2.2. Single Analyte Kits
8.3. Instruments
8.3.1. Bench Top Analyzers
8.3.2. Handheld Devices
8.4. Reagents
8.4.1. Bulk Reagents
8.4.2. Ready To Use Reagents
9. Cardiac Marker Testing Market, by Technology
9.1. Introduction
9.2. Immunoassay
9.2.1. Chemiluminescence Immunoassay
9.2.2. ELISA
9.3. Lab Automation
9.3.1. Semi Automated Analyzers
9.3.2. Walkaway Systems
9.4. Point Of Care
9.4.1. Biosensor Based Devices
9.4.2. Lateral Flow Immunoassay
10. Cardiac Marker Testing Market, by End User
10.1. Introduction
10.2. Clinics
10.2.1. Cardiac Clinics
10.2.2. Outpatient Clinics
10.3. Diagnostic Labs
10.4. Hospitals
10.4.1. Community Hospitals
10.4.2. Tertiary Hospitals
11. Cardiac Marker Testing Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. Cardiac Marker Testing Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. Cardiac Marker Testing Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Agilent Technologies, Inc.
15.3. Assure Tech (Hangzhou) Co., Ltd.
15.4. Atlas Medical GmbH
15.5. Becton, Dickinson and Company
15.6. Bio-Rad Laboratories, Inc.
15.7. Bio-Techne Corporation
15.8. Biomérieux SA
15.9. Boditech Med Inc.
15.10. Charles River Laboratories International, Inc.
15.11. Cleerly, Inc.
15.12. Danaher Corporation
15.13. DiaSorin S.p.A.
15.14. Eurofins Scientific SE
15.15. F. Hoffmann-La Roche AG
15.16. HyTest Ltd.
15.17. Laboratory Corporation of America Holdings
15.18. LightDeck Diagnostics
15.19. Merck KGaA
15.20. Natera, Inc.
15.21. PerkinElmer Inc.
15.22. Qiagen N.V.
15.23. Quest Diagnostics
15.24. QuidelOrtho Corporation
15.25. Randox Laboratories Ltd.
15.26. Sekbio
15.27. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
15.28. Siemens Healthineers AG
15.29. Thermo Fisher Scientific Inc.
15.30. Tosoh Corporation
List of Figures
FIGURE 1. GLOBAL CARDIAC MARKER TESTING MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL CARDIAC MARKER TESTING MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL CARDIAC MARKER TESTING MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL CARDIAC MARKER TESTING MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
FIGURE 9. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL CARDIAC MARKER TESTING MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL CARDIAC MARKER TESTING MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL CARDIAC MARKER TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL CK-MB MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL CK-MB MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL CK-MB MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL LDH MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL LDH MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL LDH MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL MYOGLOBIN MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL MYOGLOBIN MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL MYOGLOBIN MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL TROPONIN I MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL TROPONIN I MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL TROPONIN I MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL CONVENTIONAL TROPONIN I MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL CONVENTIONAL TROPONIN I MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL CONVENTIONAL TROPONIN I MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL HIGH SENSITIVITY TROPONIN I MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL HIGH SENSITIVITY TROPONIN I MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL HIGH SENSITIVITY TROPONIN I MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL TROPONIN T MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL TROPONIN T MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL TROPONIN T MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CONVENTIONAL TROPONIN T MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CONVENTIONAL TROPONIN T MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CONVENTIONAL TROPONIN T MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL HIGH SENSITIVITY TROPONIN T MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL HIGH SENSITIVITY TROPONIN T MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL HIGH SENSITIVITY TROPONIN T MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ASSAY KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ASSAY KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ASSAY KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL MULTIPLEX KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL MULTIPLEX KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL MULTIPLEX KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SINGLE ANALYTE KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SINGLE ANALYTE KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SINGLE ANALYTE KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL BENCH TOP ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL BENCH TOP ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL BENCH TOP ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL HANDHELD DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HANDHELD DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL HANDHELD DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL BULK REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL BULK REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL BULK REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL READY TO USE REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL READY TO USE REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL READY TO USE REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL LAB AUTOMATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL LAB AUTOMATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL LAB AUTOMATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL SEMI AUTOMATED ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL SEMI AUTOMATED ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL SEMI AUTOMATED ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL WALKAWAY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL WALKAWAY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL WALKAWAY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL POINT OF CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL POINT OF CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL POINT OF CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL BIOSENSOR BASED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL BIOSENSOR BASED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL BIOSENSOR BASED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL LATERAL FLOW IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CARDIAC CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CARDIAC CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL CARDIAC CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL OUTPATIENT CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL OUTPATIENT CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL OUTPATIENT CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DIAGNOSTIC LABS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL COMMUNITY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL TERTIARY HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 125. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 126. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 127. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 128. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 129. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 130. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 131. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 132. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 133. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 134. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 135. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 136. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 137. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 138. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 139. NORTH AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 140. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 141. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 142. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 143. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 144. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 145. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 146. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 147. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 148. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 149. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 150. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 151. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 152. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 154. LATIN AMERICA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 155. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 156. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 157. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 158. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 159. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 160. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 161. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 162. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 163. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 164. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 165. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 166. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 167. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 168. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 169. EUROPE CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 170. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 172. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 173. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 174. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 175. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 176. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 177. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 178. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 179. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 180. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 181. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 182. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 183. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 184. MIDDLE EAST CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 185. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 186. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 187. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 188. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 189. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 190. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 191. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 192. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 193. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 194. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 195. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 196. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 197. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 198. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 199. AFRICA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 200. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 201. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 202. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 203. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 204. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 205. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 206. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 207. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 208. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 209. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 210. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 211. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 212. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 213. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 214. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 215. ASEAN CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 216. GCC CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 217. GCC CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 218. GCC CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 219. GCC CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 220. GCC CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 221. GCC CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 222. GCC CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 223. GCC CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 224. GCC CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 225. GCC CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 226. GCC CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 227. GCC CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 228. GCC CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 229. GCC CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 230. GCC CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 231. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 232. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 233. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 234. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 235. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 236. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 237. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 238. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 239. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 240. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 241. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 242. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 243. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 244. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 245. EUROPEAN UNION CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 246. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 248. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 249. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 250. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 251. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 252. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 253. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 254. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 255. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 256. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 257. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 258. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 259. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 260. BRICS CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 261. G7 CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 262. G7 CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 263. G7 CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 264. G7 CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 265. G7 CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 266. G7 CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 267. G7 CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 268. G7 CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 269. G7 CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 270. G7 CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 271. G7 CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 272. G7 CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 273. G7 CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 274. G7 CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 275. G7 CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 276. NATO CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 277. NATO CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 278. NATO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 279. NATO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 280. NATO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 281. NATO CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 282. NATO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 283. NATO CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 284. NATO CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 285. NATO CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 286. NATO CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 287. NATO CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 288. NATO CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 289. NATO CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 290. NATO CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 291. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 292. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 293. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 294. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 295. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 296. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 297. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 298. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 299. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 300. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 301. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 302. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 303. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 304. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 305. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 306. UNITED STATES CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 307. CANADA CARDIAC MARKER TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 308. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 309. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 310. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 311. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 312. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 313. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 314. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 315. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 316. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 317. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 318. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 319. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 320. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 321. CANADA CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 322. MEXICO CARDIAC MARKER TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 323. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 324. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 325. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 326. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 327. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 328. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 329. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 330. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 331. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 332. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 333. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 334. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 335. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 336. MEXICO CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 337. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 338. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 339. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 340. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 341. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 342. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 343. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 344. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 345. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 346. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 347. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY LAB AUTOMATION, 2017-2032 (USD MILLION)
TABLE 348. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY POINT OF CARE, 2017-2032 (USD MILLION)
TABLE 349. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 350. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY CLINICS, 2017-2032 (USD MILLION)
TABLE 351. BRAZIL CARDIAC MARKER TESTING MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 352. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 353. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY MARKER TYPE, 2017-2032 (USD MILLION)
TABLE 354. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN I, 2017-2032 (USD MILLION)
TABLE 355. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TROPONIN T, 2017-2032 (USD MILLION)
TABLE 356. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY PRODUCT, 2017-2032 (USD MILLION)
TABLE 357. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY ASSAY KITS, 2017-2032 (USD MILLION)
TABLE 358. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 359. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY REAGENTS, 2017-2032 (USD MILLION)
TABLE 360. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 361. UNITED KINGDOM CARDIAC MARKER TESTING MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 362. UNITED KINGDOM CARDIAC MARKER TESTING MAR

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Assure Tech (Hangzhou) Co., Ltd.
  • Atlas Medical GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Biomérieux SA
  • Boditech Med Inc.
  • Charles River Laboratories International, Inc.
  • Cleerly, Inc.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • HyTest Ltd.
  • Laboratory Corporation of America Holdings
  • LightDeck Diagnostics
  • Merck KGaA
  • Natera, Inc.
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Sekbio
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Tosoh Corporation

Table Information

Report AttributeDetails
No. of Pages185
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 9.82 Billion
Forecasted Market Value ( USD ) by 2032 $ 21.4 Billion
Compound Annual Growth Rate13.6%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

Cardiac Marker Market - Global Forecast 2026-2032 - Product Image

Cardiac Marker Market - Global Forecast 2026-2032

  • Report
  • 188 Pages
  • Global
From
Cardiac Marker Analyzer Market - Global Forecast 2026-2032 - Product Image

Cardiac Marker Analyzer Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Cardiac Marker Testing Market by Product, Biomarker, Technology, Indication, Assay Format, Point of Testing - Global Forecast to 2031 - Product Image

Cardiac Marker Testing Market by Product, Biomarker, Technology, Indication, Assay Format, Point of Testing - Global Forecast to 2031

  • Report
  • 216 Pages
  • Global
From
Cardiac Marker Testing Market Report 2026 - Product Image

Cardiac Marker Testing Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cardiac Marker Testing Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Cardiac Marker Testing Products - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From

About the Market

The Cardiac Marker Testing market is a subset of the Laboratory Testing market, which focuses on the diagnosis and monitoring of cardiac diseases. Cardiac markers are proteins or enzymes released into the bloodstream in response to cardiac injury or stress. These markers can be used to diagnose and monitor a variety of cardiac conditions, such as myocardial infarction, congestive heart failure, and arrhythmias. Cardiac marker testing is typically performed using immunoassay techniques, such as ELISA, CLIA, and chemiluminescence. Cardiac marker testing is an important tool for the diagnosis and management of cardiac diseases, and is used in both clinical and research settings. It is also used to monitor the effectiveness of treatments and to assess the risk of future cardiac events. Companies in the Cardiac Marker Testing market include Abbott Laboratories, Beckman Coulter, Siemens Healthineers, Roche Diagnostics, and Ortho Clinical Diagnostics. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.